Successful treatment with Yokukansan for behavioral and psychological symptoms of Parkinsonian dementia

被引:41
作者
Kawanabe, Tadaaki
Yoritaka, Asako [1 ]
Shimura, Hideki
Oizumi, Hideki
Tanaka, Shigeki
Hattori, Nobutaka [1 ]
机构
[1] Juntendo Univ, Sch Med, Dept Neurol, Tokyo, Japan
关键词
BPSD; Dementia; Hallucination; Parkinson's disease; Yokukansan; YI-GAN-SAN; LEWY BODIES; GLUTAMATE; RATS;
D O I
10.1016/j.pnpbp.2009.11.019
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
Objective: To evaluate the efficacy and safety of Yokukansan, a traditional Chinese herbal medicine, for treating behavioral and psychological symptoms of dementia (BPSD) in patients with Parkinson disease (PD; n = 7) and those with PD with dementia (PDD; n = 7). Background: BPSD are often seen in patients with senile dementia and have serious deleterious effects on the lives of patients and caregivers. Recent studies indicate that the traditional Chinese herbal medicine Yokukansan may be safe and beneficial for the treatment of BPSD patients. Methods: We treated 7 PD and 7 PDD patients for 4 weeks with Yokukansan and observed them without Yokukansan for 4 weeks. Changes in behavioral and psychological symptoms were evaluated every 4 weeks according to the Neuropsychiatric Inventory (NPI) scale. Results: Significant improvements in behavioral and psychological symptoms, particularly in the incidence and duration of hallucinations, were observed in most PD and PDD patients after 4 weeks of Yokukansan treatment. No significant changes were observed in the laboratory tests, cognitive function, activities of daily living, or parkinsonism. Conclusion: Our results suggest that Yokukansan improves BPSD in both PD and PDD patients without worsening their cognitive function, ability to perform activities of daily living, or parkinsonism. Crown Copyright (C) 2009 Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:284 / 287
页数:4
相关论文
共 12 条
[1]
Ishibashi A, 2006, YAKUGAKU ZASSHI, V126, P82
[2]
A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients [J].
Iwasaki, K ;
Satoh-Nakagawa, T ;
Maruyama, M ;
Monma, Y ;
Nemoto, M ;
Tomita, N ;
Tanji, H ;
Fujiwara, H ;
Seki, T ;
Fujii, M ;
Arai, H ;
Sasaki, H .
JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (02) :248-252
[3]
Effects of the traditional Chinese herbal medicine Yi-Gan San for cholinesterase inhibitor-resistant visual hallucinations and neuropsychiatric symptoms in patients with dementia with Lewy bodies [J].
Iwasaki, K ;
Maruyama, M ;
Tomita, N ;
Furukawa, K ;
Nemoto, M ;
Fujiwara, H ;
Seki, T ;
Fujii, M ;
Kodama, M ;
Arai, H .
JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (12) :1612-1613
[4]
Liao Jyh-Fei, 1995, Proceedings of the National Science Council Republic of China Part B Life Sciences, V19, P151
[5]
Lidstone SC, 2007, MOL IMAGING BIOL, V9, P176, DOI 10.1007/s11307-007-0086-3
[6]
Diagnosis and management of dementia with Lewy bodies - Third report of the DLB consortium [J].
McKeith, IG ;
Dickson, DW ;
Lowe, J ;
Emre, M ;
O'Brien, JT ;
Feldman, H ;
Cummings, J ;
Duda, JE ;
Lippa, C ;
Perry, EK ;
Aarsland, D ;
Arai, H ;
Ballard, CG ;
Boeve, B ;
Burn, DJ ;
Costa, D ;
Del Ser, T ;
Dubois, B ;
Galasko, D ;
Gauthier, S ;
Goetz, CG ;
Gomez-Tortosa, E ;
Halliday, G ;
Hansen, LA ;
Hardy, J ;
Iwatsubo, T ;
Kalaria, RN ;
Kaufer, D ;
Kenny, RA ;
Korczyn, A ;
Kosaka, K ;
Lee, VMY ;
Lees, A ;
Litvan, I ;
Londos, E ;
Lopez, OL ;
Minoshima, S ;
Mizuno, Y ;
Molina, JA ;
Mukaetova-Ladinska, EB ;
Pasquier, F ;
Perry, RH ;
Schulz, JB ;
Trojanowski, JQ ;
Yamada, M .
NEUROLOGY, 2005, 65 (12) :1863-1872
[7]
Donepezil for the treatment of behavioral symptoms in patients with Alzheimer's disease [J].
Paleacu, D ;
Mazeh, D ;
Mirecki, I ;
Even, M ;
Barak, Y .
CLINICAL NEUROPHARMACOLOGY, 2002, 25 (06) :313-317
[8]
Pharmacological treatment of non-cognitive disturbances in dementia disorders [J].
Parnetti, L ;
Amici, S ;
Lanari, A ;
Gallai, V .
MECHANISMS OF AGEING AND DEVELOPMENT, 2001, 122 (16) :2063-2069
[9]
Quetiapine versus risperidone in elderly patients with behavioural and psychological symptoms of dementia: Efficacy, safety and cognitive function [J].
Rainer, M. ;
Haushofer, M. ;
Pfolz, H. ;
Struhal, C. ;
Wick, W. .
EUROPEAN PSYCHIATRY, 2007, 22 (06) :395-403
[10]
Evaluation of the protective effects of alkaloids isolated from the hooks and stems of Uncaria sinensis on glutamate-induced neuronal death in cultured cerebellar granule cells from rats [J].
Shimada, Y ;
Goto, H ;
Itoh, T ;
Sakakibara, I ;
Kubo, M ;
Sasaki, H ;
Terasawa, K .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1999, 51 (06) :715-722